Td Asset Management Inc Oncolytics Biotech Inc Transaction History

Td Asset Management Inc

  • $107 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 09, 2021
SELL
$1.93 - $2.77 $100,373 - $144,059
-52,007 Closed
0 $0
Q2 2021

Aug 11, 2021
BUY
$2.6 - $4.64 $135,218 - $241,312
52,007 New
52,007 $120,000

Others Institutions Holding ONCY

# of Institutions
44
Shares Held
1.18M
Call Options Held
0
Put Options Held
0
View Full List

About ONCOLYTICS BIOTECH INC

ONCY Quotes by TradingView
  • Ticker ONCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,867,400
  • Market Cap $49.2M
  • Description
  • Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...
More about ONCY
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email